Stocktoria
AGIOS PHARMACEUTICALS, INC. AGIO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-07-24
AGIOS PHARMACEUTICALS, INC. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $54.0M | $36.5M | $26.8M | $14.2M | $0 |
| R&D expense | $339.5M | $301.3M | $295.5M | $279.9M | $257.0M |
| SG&A expense | $180.3M | $156.8M | $119.9M | $121.7M | $121.4M |
| Operating income | -$472.1M | -$425.7M | -$391.5M | -$389.0M | -$378.4M |
| Income tax | -$1.0M | $44.2M | $0 | $0 | — |
| Net income | -$412.8M | $673.7M | -$352.1M | -$231.8M | $1.6B |
| EPS (diluted) | $-7.12 | $11.64 | $-6.33 | $-4.23 | $26.55 |
| Operating cash flow | -$373.0M | -$389.8M | -$296.1M | -$309.5M | -$407.3M |
| Free cash flow | -$377.3M | -$391.5M | -$297.1M | -$314.4M | -$413.1M |
| Cash & equivalents | $89.1M | $76.2M | $88.2M | $139.3M | $203.1M |
| Inventory | $32.9M | $27.6M | $19.1M | $8.5M | $0 |
| Total assets | $1.3B | $1.7B | $937.1M | $1.2B | $1.4B |
| Total liabilities | $104.1M | $122.2M | $126.1M | $137.9M | $145.8M |
| Shareholders' equity | $1.2B | $1.5B | $811.0M | $1.1B | $1.3B |
Source: SEC EDGAR filings · CIK 0001439222 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.